Qube Research & Technologies LTD Fate Therapeutics Inc Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 10,422 shares of FATE stock, worth $17,300. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,422
Previous 35,134 70.34%
Holding current value
$17,300
Previous $115,000 68.7%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$3.12 - $5.57 $77,101 - $137,645
-24,712 Reduced 70.34%
10,422 $36,000
Q2 2024

Aug 14, 2024
BUY
$3.26 - $7.08 $77,666 - $168,673
23,824 Added 210.65%
35,134 $115,000
Q1 2024

May 14, 2024
SELL
$3.54 - $8.35 $145,607 - $343,452
-41,132 Reduced 78.43%
11,310 $83,000
Q4 2023

Feb 13, 2024
SELL
$1.65 - $3.94 $554,093 - $1.32 Million
-335,814 Reduced 86.49%
52,442 $196,000
Q3 2023

Nov 13, 2023
BUY
$2.02 - $5.04 $423,410 - $1.06 Million
209,609 Added 117.33%
388,256 $823,000
Q2 2023

Aug 14, 2023
BUY
$4.76 - $6.59 $770,515 - $1.07 Million
161,873 Added 965.02%
178,647 $850,000
Q1 2023

May 15, 2023
SELL
$4.24 - $11.12 $2.01 Million - $5.28 Million
-475,208 Reduced 96.59%
16,774 $95,000
Q4 2022

Feb 14, 2023
BUY
$9.86 - $23.83 $4.62 Million - $11.2 Million
468,892 Added 2030.71%
491,982 $4.96 Million
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $485,813 - $832,625
23,090 New
23,090 $517,000
Q4 2021

Feb 01, 2022
SELL
$47.84 - $64.34 $619,910 - $833,717
-12,958 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$59.27 - $95.73 $567,688 - $916,901
-9,578 Reduced 42.5%
12,958 $768,000
Q2 2021

Aug 13, 2021
BUY
$67.25 - $92.52 $886,489 - $1.22 Million
13,182 Added 140.92%
22,536 $1.96 Million
Q1 2021

May 14, 2021
BUY
$72.16 - $117.4 $674,984 - $1.1 Million
9,354 New
9,354 $771,000
Q1 2020

May 15, 2020
SELL
$17.28 - $31.88 $235,837 - $435,098
-13,648 Closed
0 $0
Q4 2019

Feb 13, 2020
BUY
$13.39 - $20.73 $182,746 - $282,923
13,648 New
13,648 $267,000

Others Institutions Holding FATE

# of Institutions
175
Shares Held
115M
Call Options Held
53.7K
Put Options Held
9K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $161M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email